HSP90, a Common Therapeutic Target for Suppressing Skin Injury Caused by Exposure to Chemically Diverse Classes of Blistering Agents
Ritesh K. Srivastava(University of Alabama at Birmingham), Mohammad Athar(University of Alabama at Birmingham)
Cited by 6
Related Papers
CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice
|Journal of Clinical Investigation|2007|133
CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas
|International Journal of Oncology|2022|33